Sales & Earnings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Hansen Medical: Firm reported a 43% drop in second-quarter revenues Aug. 4 -- to $3.3 million from $5.8 million in the same quarter of 2008 -- with lower-than-expected sales of the Sensei robotic catheter system. Hansen shipped six Sensei systems in the quarter, but only recognized revenue on three. Firm anticipates FDA clearance of an enhanced Sensei platform and Artisan catheter in the third quarter, and hopes to launch a smaller, more flexible ablation catheter in Europe in early 2010. The firm is working on a new platform for complex vascular procedures, but CEO Fred Moll says a clinical trial is not likely to begin before 2010 (1"The Gray Sheet" Dec. 8, 2008)